NDC 70518-3080

Biktarvy

Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate

Biktarvy is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Bictegravir Sodium; Emtricitabine; Tenofovir Alafenamide Fumarate.

• Product ID: 70518-3080_c109cddc-e382-3c5c-e053-2a95a90a455a
• NDC: 70518-3080
• Product Type: Human Prescription Drug
• Proprietary Name: Biktarvy
• Generic Name: Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2021-04-28
• Marketing Category: NDA /
• Application Number: NDA210251
• Labeler Name: REMEDYREPACK INC.
• Substance Name: BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
• Active Ingredient Strength: 50 mg/1; mg/1; mg/1
• Pharm Classes: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 70518-3080-0

3 TABLET in 1 BLISTER PACK (70518-3080-0)

• Marketing Start Date: 2021-04-28
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Biktarvy" or generic name "Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate"

NDC	Brand Name	Generic Name
50090-6247	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
61958-2501	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
61958-2505	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
70518-3080	Biktarvy	bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate